MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.
<h4>Background</h4>Dysregulation of microRNA (miRNA) expression in various tissues and body fluids has been demonstrated to be associated with several diseases, including Type 2 Diabetes mellitus (T2D). Here, we compare miRNA expression profiles in different tissues (pancreas, liver, adi...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b78a30c47c394b16a2e7281951e31234 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b78a30c47c394b16a2e7281951e31234 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b78a30c47c394b16a2e7281951e312342021-11-18T06:48:55ZMicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.1932-620310.1371/journal.pone.0022839https://doaj.org/article/b78a30c47c394b16a2e7281951e312342011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21829658/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Dysregulation of microRNA (miRNA) expression in various tissues and body fluids has been demonstrated to be associated with several diseases, including Type 2 Diabetes mellitus (T2D). Here, we compare miRNA expression profiles in different tissues (pancreas, liver, adipose and skeletal muscle) as well as in blood samples from T2D rat model and highlight the potential of circulating miRNAs as biomarkers of T2D. In parallel, we have examined the expression profiles of miRNAs in blood samples from Impaired Fasting Glucose (IFG) and T2D male patients.<h4>Methodology/principal findings</h4>Employing miRNA microarray and stem-loop real-time RT-PCR, we identify four novel miRNAs, miR-144, miR-146a, miR-150 and miR-182 in addition to four previously reported diabetes-related miRNAs, miR-192, miR-29a, miR-30d and miR-320a, as potential signature miRNAs that distinguished IFG and T2D. Of these microRNAs, miR-144 that promotes erythropoiesis has been found to be highly up-regulated. Increased circulating level of miR-144 has been found to correlate with down-regulation of its predicted target, insulin receptor substrate 1 (IRS1) at both mRNA and protein levels. We could also experimentally demonstrate that IRS1 is indeed the target of miR-144.<h4>Conclusion</h4>We demonstrate that peripheral blood microRNAs can be developed as unique biomarkers that are reflective and predictive of metabolic health and disorder. We have also identified signature miRNAs which could possibly explain the pathogenesis of T2D and the significance of miR-144 in insulin signaling.Dwi Setyowati KarolinaArunmozhiarasi ArmugamSubramaniam TavintharanMichael T K WongSu Chi LimChee Fang SumKandiah JeyaseelanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e22839 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Dwi Setyowati Karolina Arunmozhiarasi Armugam Subramaniam Tavintharan Michael T K Wong Su Chi Lim Chee Fang Sum Kandiah Jeyaseelan MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. |
| description |
<h4>Background</h4>Dysregulation of microRNA (miRNA) expression in various tissues and body fluids has been demonstrated to be associated with several diseases, including Type 2 Diabetes mellitus (T2D). Here, we compare miRNA expression profiles in different tissues (pancreas, liver, adipose and skeletal muscle) as well as in blood samples from T2D rat model and highlight the potential of circulating miRNAs as biomarkers of T2D. In parallel, we have examined the expression profiles of miRNAs in blood samples from Impaired Fasting Glucose (IFG) and T2D male patients.<h4>Methodology/principal findings</h4>Employing miRNA microarray and stem-loop real-time RT-PCR, we identify four novel miRNAs, miR-144, miR-146a, miR-150 and miR-182 in addition to four previously reported diabetes-related miRNAs, miR-192, miR-29a, miR-30d and miR-320a, as potential signature miRNAs that distinguished IFG and T2D. Of these microRNAs, miR-144 that promotes erythropoiesis has been found to be highly up-regulated. Increased circulating level of miR-144 has been found to correlate with down-regulation of its predicted target, insulin receptor substrate 1 (IRS1) at both mRNA and protein levels. We could also experimentally demonstrate that IRS1 is indeed the target of miR-144.<h4>Conclusion</h4>We demonstrate that peripheral blood microRNAs can be developed as unique biomarkers that are reflective and predictive of metabolic health and disorder. We have also identified signature miRNAs which could possibly explain the pathogenesis of T2D and the significance of miR-144 in insulin signaling. |
| format |
article |
| author |
Dwi Setyowati Karolina Arunmozhiarasi Armugam Subramaniam Tavintharan Michael T K Wong Su Chi Lim Chee Fang Sum Kandiah Jeyaseelan |
| author_facet |
Dwi Setyowati Karolina Arunmozhiarasi Armugam Subramaniam Tavintharan Michael T K Wong Su Chi Lim Chee Fang Sum Kandiah Jeyaseelan |
| author_sort |
Dwi Setyowati Karolina |
| title |
MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. |
| title_short |
MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. |
| title_full |
MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. |
| title_fullStr |
MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. |
| title_full_unstemmed |
MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. |
| title_sort |
microrna 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/b78a30c47c394b16a2e7281951e31234 |
| work_keys_str_mv |
AT dwisetyowatikarolina microrna144impairsinsulinsignalingbyinhibitingtheexpressionofinsulinreceptorsubstrate1intype2diabetesmellitus AT arunmozhiarasiarmugam microrna144impairsinsulinsignalingbyinhibitingtheexpressionofinsulinreceptorsubstrate1intype2diabetesmellitus AT subramaniamtavintharan microrna144impairsinsulinsignalingbyinhibitingtheexpressionofinsulinreceptorsubstrate1intype2diabetesmellitus AT michaeltkwong microrna144impairsinsulinsignalingbyinhibitingtheexpressionofinsulinreceptorsubstrate1intype2diabetesmellitus AT suchilim microrna144impairsinsulinsignalingbyinhibitingtheexpressionofinsulinreceptorsubstrate1intype2diabetesmellitus AT cheefangsum microrna144impairsinsulinsignalingbyinhibitingtheexpressionofinsulinreceptorsubstrate1intype2diabetesmellitus AT kandiahjeyaseelan microrna144impairsinsulinsignalingbyinhibitingtheexpressionofinsulinreceptorsubstrate1intype2diabetesmellitus |
| _version_ |
1718424375567319040 |